Articles highlighting global pharmaceutical market issues.
- End of the Road for UK Price Regulation Scheme?
Cambridge Pharma considers the outlook for the UK Pharmaceutical Price Regulation Scheme, designed to keep drugs affordable for the state-run health service.
Apr 29, 2007
- IMS Retail Drug Monitor - February 2007
The February edition of IMS Retail Drug Monitor shows a 5% growth in drug sales through retail pharmacies in 13 key markets in the 12-month period from March 2006 through to February 2007, closing at US$ 392 billion.
Apr 23, 2007
- IMS Retail Drug Monitor - January 2007
The January edition of IMS Retail Drug Monitor shows a 5% growth in drug sales through retail pharmacies in 13 key markets in the 12-month period from February 2006 through to January 2007, closing at US$ 390.2 billion.
Apr 10, 2007
- IMS Retail Drug Monitor May 2007
The May edition of IMS Retail Drug Monitor shows a 5% growth in drug sales through retail pharmacies in 13 key markets in the 12-month period from June 2006 through to May 2007, closing at US$ 399.5 billion.
Apr 8, 2007
- IMS Retail Drug Monitor April 2007
The April edition of IMS Retail Drug Monitor shows a 5% growth in drug sales through retail pharmacies in 13 key markets in the 12-month period from May 2006 through to April 2007, closing at US$ 398.01 billion.
Apr 5, 2007
- Changing market dynamics in 2007
Emerging markets, biotechs, generics and specialty-initiated products are all expected to see robust growth over 2007.
Dec 5, 2006
- New products and markets fuel growth in 2005
IMS’ annual sales review reveals moderated growth overall in 2005, but increasing impetus from developing markets and new products.
May 8, 2006
- The five components of launch success
Planning ahead is key to ensuring the successful launch of a new pharmaceutical product.
Dec 15, 2005
- Biotech in Canada - striving to reach potential
A look at the issues that arose from the domestic industry during the BioFinance 2005 meeting, held in Toronto, including access to finance, corporate governance, and the importation of drugs to the US.
Aug 2, 2005
- No more sleepless nights for Sepracor?
Sales of Lunesta, the first sleeping pill that can be taken long term, have got off to a flying start – but new competitors are nigh.
Jul 29, 2005
